Skip to content
MajorhouseExpert

Zimbabwe Turns Down ‘One-Sided’ American Health Aid Deal Due to Data Fears

Medical aid image
The offered American funding was aimed at programmes for treating and preventing HIV/Aids, tuberculosis, and malarial diseases.

The nation of Zimbabwe has declined a major US health deal worth 367 million US dollars (£272m) spanning five years due to Washington's demand for sensitive information.

The decision came to light after a government memo from December was leaked, which showed President Emmerson Mnangagwa felt the deal was "skewed".

An official spokesman later explained that the US was seeking biological samples for scientific study and commercial gain while refused to guarantee the resulting advantages from future treatments.

"We will now turn to the challenging and unfortunate task of winding down our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.

Her embassy said the United States had donated more than $1.9bn for health programmes to Zimbabwe during the past two decades.

A doctors' association in Zimbabwe has appealed for further dialogue to secure a deal acceptable to all parties so the nation's critical HIV treatment initiative can proceed.

Broader Context

Zimbabwe's decision follows a similar case in Kenya, where a court halted a related health funding agreement after legal challenges were raised about the safety of citizens' health data.

After resuming the presidency recently, US President Donald Trump has drastically cut overseas assistance and shut down the key foreign aid agency.

USAID had overseen aid for the US government, but Trump argued its spending was "inefficient" and his administration was pursuing government-to-government deals to boost openness and accountability.

According to statements, 16 African countries have so far signed these new agreements, representing over $18.3bn of fresh investment.

Details of the Declined Deal

The money for Zimbabwe was intended to gone towards "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"We believe this collaboration would have delivered significant advantages for the people of Zimbabwe, especially the 1.2 million men, women and children currently receiving antiretroviral therapy through American-funded initiatives," Tremont commented.

However, government spokesperson Nick Mangwana said the proposed deal was "unequal".

"The proposal required Zimbabwe to surrender its genetic material and health information for a long time, without any equivalent guarantee of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," his statement read.

"In essence, our country would supply the raw materials for medical research without any certainty that the end products would be accessible to our citizens if a new health crisis emerge."

National Interest and International Frameworks

Mangwana further pointed out that the American exit from the global health body and its pursuit of bilateral health agreements were disrupting systems previously set up via the global organization.

The spokesperson cited its Pandemic Benefit-Sharing framework created to manage potential pandemics.

"This mechanism is intended to ensure that when a country contributes its information, the resulting advantages – including vaccines and treatments – are shared equitably, not commercialised exclusively by those with the funds to develop them."

These objections over the US deal "must not be interpreted as hostility towards the US," he added.

"We are open to ongoing dialogue with our American counterparts on how future collaboration might be arranged in a way that honours the sovereignty and dignity of each country."

Health Experts Response

Medical experts said it understood the government's concerns, but recommended that talks must proceed since a large portion of the nation's Aids initiatives depended on foreign aid.

"In cases where specific concerns arise, such as those involving data governance or implementation frameworks, these can frequently be resolved via technical clarification and mutually agreed protections," it added.

The halted deal highlights the continuing challenges between receiving vital international aid and safeguarding a country's data in an ever more data-driven world.

By

Robert Rodriguez

Lena Visser is a professional interior designer and home improvement specialist with over 10 years of experience in transforming spaces.

MajorhouseExpert

Type to search articles.